Physician profile
William C Winter
NPI 1841264942
$1,061,384.72
in general payments reported to CMS, 2019-2025
7 companies · $255K in 2025
The $255K reported for 2025 was more than what 99% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86K · 2020: $124K · 2021: $149K · 2022: $165K · 2023: $184K · 2024: $99K · 2025: $255K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $213K · Consulting Fee: $140K · Honoraria: $92K · Travel and Lodging: $56K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $28K · Food and Beverage: $8,731 · Education: $97.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $213,070.00 |
| Consulting Fee | $139,724.50 |
| Honoraria | $92,348.00 |
| Travel and Lodging | $56,011.24 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $28,000.00 |
| Food and Beverage | $8,731.49 |
| Education | $97.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $473,806.94 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $373,663.55 | 2020-2025 | Wakix |
| Axsome Therapeutics, INC. | $167,160.52 | 2023-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $42,216.32 | 2024-2025 | Lumryz |
| Lilly USA, LLC | $4,500.00 | 2025 | |
| Promius Pharma LLC | $19.94 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.